Standard Standard

Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. / Macdonald, J.H.; Marcora, S.M.; Jibani, M.M. et al.
In: Nephron Clinical Practice, Vol. 106, No. 3, 01.07.2007, p. 125-135.

Research output: Contribution to journalArticlepeer-review

HarvardHarvard

Macdonald, JH, Marcora, SM, Jibani, MM, Kumwenda, MJ, Ahmed, W & Lemmey, AB 2007, 'Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.', Nephron Clinical Practice, vol. 106, no. 3, pp. 125-135. https://doi.org/10.1159/000103000

APA

CBE

MLA

VancouverVancouver

Macdonald JH, Marcora SM, Jibani MM, Kumwenda MJ, Ahmed W, Lemmey AB. Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. Nephron Clinical Practice. 2007 Jul 1;106(3):125-135. doi: 10.1159/000103000

Author

Macdonald, J.H. ; Marcora, S.M. ; Jibani, M.M. et al. / Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study. In: Nephron Clinical Practice. 2007 ; Vol. 106, No. 3. pp. 125-135.

RIS

TY - JOUR

T1 - Nandrolone decanoate as anabolic therapy in chronic kidney disease: A randomized phase II dose-finding study.

AU - Macdonald, J.H.

AU - Marcora, S.M.

AU - Jibani, M.M.

AU - Kumwenda, M.J.

AU - Ahmed, W.

AU - Lemmey, A.B.

PY - 2007/7/1

Y1 - 2007/7/1

KW - UROLOGY & NEPHROLOGY

U2 - 10.1159/000103000

DO - 10.1159/000103000

M3 - Article

VL - 106

SP - 125

EP - 135

JO - Nephron Clinical Practice

JF - Nephron Clinical Practice

SN - 1660-2110

IS - 3

ER -